PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h0m. Bisher sind 713 Folge(n) erschienen. Alle 2 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 29 days 19 hours 25 minutes

subscribe
share






Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, FAAN - Reaching the Next Level of Myeloma Patient Care: Oncology Nurse Guidance on Antibody Therapy and Novel Mechanisms of Action


Go online to PeerView.com/BRG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 26, 2022  35m
 
 

Elena Elez, MD, PhD - Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents


Go online to PeerView.com/NEB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 12, 2022  1h18m
 
 

Robert Z. Orlowski, MD, PhD - Building Real-World Bridges Between Clinicians and Patients With Myeloma: Guidance on Innovative Antibody Options


Go online to PeerView.com/JPJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 12, 2022  1h7m
 
 

Prof. Carmelo Rizzari - The Path for Better Outcomes in ALL: Integrating Modern Asparaginase Compounds Into the Care of Pediatric, AYA, and Adult Patients


Go online to PeerView.com/JFN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 11, 2022  1h2m
 
 

Sagar Lonial, MD, FACP - Navigating From A to B and C in Multiple Myeloma: Delivering High-Quality Care With mAbs, BCMA ADCs, and Cellular Therapy


Go online to PeerView.com/VDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 10, 2022  1h4m
 
 

Yelena Y. Janjigian, MD - Moving the Treatment of Advanced Gastroesophageal Cancers Forward: How Can We Maximize the Benefits of Novel Immunotherapy Approaches?


Go online to PeerView.com/NTS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 10, 2022  47m
 
 
share








 August 10, 2022  1h9m
 
 

Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice


Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 6, 2022  1h30m
 
 

Michael B. Atkins, MD - Choosing Innovation With Immunotherapy in Melanoma: Guidance on Utilizing Immune-Based and Other Novel Options in Resectable and Unresectable Disease


Go online to PeerView.com/NDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 6, 2022  1h21m
 
 

Hussein A. Tawbi, MD, PhD - New Rules for Sequential Care in BRAF-Mutated Melanoma: Rethinking Upfront Selection and Sequencing of Immunotherapy and Targeted Agents in Metastatic Disease


Go online to PeerView.com/ZBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 6, 2022  1h2m